The USD 200mil will be the brand, reference listed drug is Aczone® and the sole generic, so yes just the Gels. Good market to play in you can get it, a duopoly that both drug manufacturers would benefit from as long as they don't cut each others throats.
Interesting point is that ACR's announcement said there is only 1 approved ANDA. Maybe the other approved ANDA you saw is a different strength,
Add to My Watchlist
What is My Watchlist?
